These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29956651)

  • 1. [An history of the CRISPR-Cas systems discovery].
    Pourcel C
    Biol Aujourdhui; 2017; 211(4):247-254. PubMed ID: 29956651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.
    Burmistrz M; Dudek B; Staniec D; Rodriguez Martinez JI; Bochtler M; Potempa J; Pyrc K
    J Bacteriol; 2015 Aug; 197(16):2631-41. PubMed ID: 26013482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers.
    Pourcel C; Touchon M; Villeriot N; Vernadet JP; Couvin D; Toffano-Nioche C; Vergnaud G
    Nucleic Acids Res; 2020 Jan; 48(D1):D535-D544. PubMed ID: 31624845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms.
    Koonin EV; Wolf YI
    Biol Direct; 2016 Feb; 11(1):9. PubMed ID: 26912144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis.
    Shmakov SA; Makarova KS; Wolf YI; Severinov KV; Koonin EV
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5307-E5316. PubMed ID: 29784811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting CRISPR/Cas: interference mechanisms and applications.
    Richter H; Randau L; Plagens A
    Int J Mol Sci; 2013 Jul; 14(7):14518-31. PubMed ID: 23857052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finally, Archaea Get Their CRISPR-Cas Toolbox.
    Gophna U; Allers T; Marchfelder A
    Trends Microbiol; 2017 Jun; 25(6):430-432. PubMed ID: 28391963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
    Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal number of spacers in CRISPR arrays.
    Martynov A; Severinov K; Ispolatov I
    PLoS Comput Biol; 2017 Dec; 13(12):e1005891. PubMed ID: 29253874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-based technologies: prokaryotic defense weapons repurposed.
    Terns RM; Terns MP
    Trends Genet; 2014 Mar; 30(3):111-8. PubMed ID: 24555991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 18. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System.
    Burmistrz M; Rodriguez Martinez JI; Krochmal D; Staniec D; Pyrc K
    J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28893837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of CRISPR-Cas spacer acquisition.
    McGinn J; Marraffini LA
    Nat Rev Microbiol; 2019 Jan; 17(1):7-12. PubMed ID: 30171202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.